стоимость билетов на матчи баварии в лиге чемпионов
Главное меню:
Интересное
стоимость билетов на матчи баварии в лиге чемпионов, Precision or Personalized Medicine - American Cancer Society, Precision Oncology - National Institutes of Health (NIH), The Future of Precision Oncology - PMC - PubMed Central (PMC), Delivering precision oncology to patients with cancer, What Is Precision Cancer Medicine? | The AACR, Precision Oncology: A Global Perspective on Implementation , Precision nanomedicine: navigating the tumor microenvironment .
Awad K, Dalby M, Cree, IA, Challoner BR, Ghosh S, Thurston DE. The precision medicine approach to cancer therapy: Part 1: Solid tumours. The Pharmaceutical Journal. 2019. Accessed at https://www.pharmaceutical-journal.com/research/review-article/the-precision-medicine-approach-to-cancer-therapy-part-1-solid-tumours/20207119.article on March 9, 2020. Bashraheel SS, Domling A, Goda SK. Update on targeted cancer therapies, single or in combination, and their fine tuning for precision medicine. Biomed Pharmacother. 2020;125:110009. doi: 10.1016/j.biopha.2020.110009. [Epub ahead of print] Davis AA, McKee AE, Kibbe WA, Villaflor VM. Complexity of delivering precision medicine: Opportunities and challenges ASCO Educational Book. 2018;38:998-1007. Accessed at https://ascopubs.org/doi/10.1200/EDBK_200279 on March 9, 2020. Doroshow DB, Doroshow JH. Genomics and the history of precision oncology. Surg Oncol Clin N Am. 2020;29(1):35-49. Ersek JL, Black LJ, Thompson MA, Kim ES. Implementing precision medicine programs and clinical trials in the community-based oncology practice: Barriers and best practices. ASCO Educational Book. 2018;38:188-196. Accessed at https://ascopubs.org/doi/10.1200/EDBK_200633 on March 9, 2020. Harvard Business School Kraft Precision Medicine Accelerator. Direct to patient: Where precision medicine starts. Accessed at https://www.hbs.edu/kraft-accelerator/workstreams/Pages/direct-to-patient.aspx on March 9, 2020. Iqvia Institute for Human Data Science. Global oncology trends: 2019. Accessed at https://www.iqvia.com/-/media/iqvia/pdfs/institute-reports/global-oncology-trends-2019.pdf?_=1583864673144 on March 9, 2020. Krzyszczyk P, et al. The growing role of precision and personalized medicine for cancer treatment. Technology. 2018;6(3-4):79-100. National Cancer Institute (NCI). Precision medicine in cancer treatment. 2017. Accessed at https://www.cancer.gov/about-cancer/treatment/types/precision-medicine on March 9, 2020. National Comprehensive Cancer Network (NCCN). Biomarker testing. Accessed at https://www.nccn.org/patients/resources/life_with_cancer/treatment/biomarker_testing.aspx on March 9, 2020. National Comprehensive Cancer Network (NCCN). Personalized medicine: One size doesn’t fit all. Accessed at https://www.nccn.org/patients/resources/life_with_cancer/treatment/personalized_medicine.aspx on March 9, 2020. Shaban-Nejad A, Michalowski M, Peek N, Brownstein JS, Buckeridge DL. Seven pillars of precision digital health and medicine. Artificial Intelligence In Medicine. 2020;103:101793. Wilson JL, Altman RB. Biomarkers: Delivering on the expectation of molecularly driven, quantitative health. Exp Biol Med. 2018;243(3):313-322. Zou J, Wang E. Cancer biomarker discovery for precision medicine: New progress. Curr Med Chem. 2019;26(42):7655-7671., Precision medicine in cancer care. Precision medicine is being used for certain cancers to help know what tests and treatment are best. Doctors might use precision medicine to help them: Identify people who might be at high risk for cancer, and help these people lower their risk; Find certain cancers early; Diagnose a specific type of cancer , They are also discovering that cancers that develop in totally different parts of the body can sometimes, on a molecular level, have a lot in common. From this new perspective emerges an exciting era in cancer research called precision oncology, in which doctors are choosing treatments based on the DNA signature of an individual patient’s tumor..
A number of molecular diagnostic tests for precision oncology products have also been co-developed to support clinical validation of precision oncology therapeutics and guide treatment decisions . Currently, more than 60 nucleic acid-based tests have been cleared or approved by the US Center for Devices and Radiological Health for oncology , Access to precision oncology is one of the key priorities included in the EU’s new Europe’s Beating Cancer Plan, which aims to improve the prevention, detection, treatment, and management of , Currently, genomics is the main factor influencing precision medicine in oncology. However, other factors, including a patient’s disease presentation, gender, lifestyle, and exposures to potential cancer-causing agents like cigarette smoke could be considered in precision medicine., The overarching goal of precision oncology (PO) is to tailor medical care to the specific characteristics of each patient's cancer, allowing for more efficacious and less toxic treatments. Currently, PO optimizes treatment outcomes by leveraging comprehensive genomic profiling, matching this to genomically targeted therapies or immunotherapies., This shift towards precision medicine holds the potential for improved efficacy. It aims to reduce side effects commonly associated with traditional therapies, ultimately fostering a more holistic approach to cancer treatment [218, 219]. This progress may facilitate new clinical trials that investigate tailored medicines'long-term impacts and , Genomic profiling of hundreds of cancer-associated genes is now a component of routine cancer care. DNA sequencing can identify mutations, mutational signatures, and structural alterations predictive of therapy response and assess for heritable cancer risk, but it has been less useful for identifyin ….